Cristin-resultat-ID: 1928610
Sist endret: 25. august 2021, 11:45
Resultat
Poster
2021

Breast Cancer Patients' Experiences with Mainstreamed Genetic Testing in Two Hospitals in South Eastern Norway - Preliminary results

Bidragsytere:
  • Nina Strømsvik
  • Pernilla Marie A. Olsson
  • Berit Gravdehaug
  • Lovise Olaug Mæhle
  • Hilde Lurås
  • Ellen Schlichting
  • mfl.

Presentasjon

Navn på arrangementet: BRCA 2021: A Vision of the Future – The Eighth International Symposium on Hereditary Breast and Ovarian Cancer
Sted: Viurtually.
Dato fra: 4. mai 2021
Dato til: 7. mai 2021

Arrangør:

Arrangørnavn: Hereditary Breast + Ovarian Cancer Foundation in Collaboration with Program in Cancer Genetics, McGill University, Montreal, Canada

Om resultatet

Poster
Publiseringsår: 2021

Beskrivelse Beskrivelse

Tittel

Breast Cancer Patients' Experiences with Mainstreamed Genetic Testing in Two Hospitals in South Eastern Norway - Preliminary results

Sammendrag

Background: In South Eastern Norway, genetic testing of BRCA1 and BRCA2 is mainstreamed into regular oncological care. Testing is offered directly to breast cancer (BC) patients by surgeons and oncologists. Only patients who test positive for a pathogenic BRCA variant or have a family history of cancer, are referred to genetic counseling. The aim of this study was to gain knowledge on how BC patients experience this health care service. Methods: Thirty women, diagnosed with BC during the first half of 2016 or 2017 at one regional and one university hospital, and who had been tested by their treating physician were invited.. Twenty two (73%) consented to inclusion, and qualitative individual interviews were undertaken with all of them. The data were analysed using a thematic approach. Results: Being diagnosed with BC was a shock that created a need for and an obstacle to absorbing and remembering information. A feeling of trust in the health care providers facilitated communication in this chaotic period. The women regarded genetic testing as important for themselves, their cancer treatment and their relatives. The participants’ experience of how genetic testing was offered, the amount of information they received and how they had received the test result varied. Not all patients had been offered testing, and some had asked for the test themselves. The participants emphasized the importance of having routines to secure that all eligible patients were given the opportunity of being tested. Conclusions: Based on the findings in this qualitative study of BC patients’ experience with mainstreamed genetic testing, we conclude that access to testing during diagnosis and treatment had been important to these women. Their varied experiences regarding when and how they had been offered testing indicate that there may be a need to strengthen and unify routines for this health care service.

Bidragsytere

Nina Strømsvik

  • Tilknyttet:
    Forfatter
    ved Barne- og ungdomsklinikken ved Universitetssykehuset Nord-Norge HF
  • Tilknyttet:
    Forfatter
    ved Institutt for helse- og omsorgsvitskap ved Høgskulen på Vestlandet

Pernilla Marie A. Olsson

  • Tilknyttet:
    Forfatter
    ved Avd Kirurgi ved Sykehuset Innlandet HF

Berit Gravdehaug

  • Tilknyttet:
    Forfatter
    ved Kirurgisk divisjon ved Akershus universitetssykehus HF

Lovise Olaug Mæhle

  • Tilknyttet:
    Forfatter
    ved Avdeling for medisinsk genetikk ved Oslo universitetssykehus HF

Hilde Lurås

  • Tilknyttet:
    Forfatter
    ved Seksjon for bryst og endokrinkirurgi ved Oslo universitetssykehus HF
1 - 5 av 11 | Neste | Siste »